Aurobindo Pharma arm Eugia Pharma Specialities gets USFDA nod for cancer drug Ruchika Sharma23 April 2025 12:53 PM ISTHyderabad: Aurobindo Pharma Limited has announced that its wholly owned subsidiary, Eugia PharmaSpecialities Limited, has received final approval...
Cipla bags USFDA nod for chronic myeloid leukemia drug Nilotinib Ruchika Sharma21 Feb 2025 11:30 AM ISTMumbai: Pharma major, Cipla, has received final approval from the United States Food and Drug Administration (USFDA) for the New Drug...
Takeda signs option agreement with Ascentage Pharma to enter into exclusive global license for Olverembatinib Ruchika Sharma16 Jun 2024 10:30 AM ISTJapan: Takeda has announced the signing of an option agreement with Ascentage Pharma to enter into an exclusive license agreement for...
Nilotinib Linked to increased diabetes and hyperlipidemia risk in Chronic Myeloid Leukemia Patients Jacinthlyn Sylvia28 Aug 2023 8:00 AM ISTA recent study published in The oncologist Journal found Nilotinib (tyrosine kinase inhibitor) therapy for chronic myeloid leukemia (CML) associated...
Aurobindo Pharma arm signs voluntary license with Medicines Patent Pool to develop generic version of Nilotinib Capsules for chronic myeloid leukemia treatment in 44 countries Ruchika Sharma23 Jun 2023 11:51 AM ISTHyderabad: Pharma major, Aurobindo Pharma Limited, has announced that its wholly-owned subsidiary company, Eugia Pharma Specialities Limited, has...
Novartis: Scemblix approved in the EU for adults with chronic myeloid leukemia Kajal Rajput29 Aug 2022 3:03 PM ISTBasel: Novartis today announced that the European Commission (EC) has approved Scemblix (asciminib) for the treatment of adult patients with...
USFDA nod to Alembic Pharma cancer drug Dasatinib Ruchika Sharma10 Jun 2022 12:58 PM ISTVadodara: Drugmaker, Alembic Pharmaceuticals Limited, today announced that the company has received tentative approval from the US Food & Drug...
Novartis Scemblix gets USFDA nod for chronic myeloid leukemia Ruchika Sharma31 Oct 2021 10:00 AM ISTBasel: Novartis has recently announced that the US Food and Drug Administration (FDA) has approved Scemblix (asciminib) for the treatment of chronic...
Novartis gets USFDA Breakthrough Therapy designations for STAMP inhibitor asciminib to treat chronic myeloid leukemia Ruchika Sharma9 Feb 2021 11:00 AM ISTAsciminib (ABL001) is an investigational treatment specifically targeting the ABL myristoyl pocket (STAMP).
Metoclopramide inhibits proliferation of leukemia stem cells, finds study Hina Zahid29 Jan 2021 12:16 AM ISTChronic myeloid leukemia (CML) results from a degeneration of the hematopoietic stem cells (leukemia stem cells), thereby leading to the uncontrolled...
Bone Marrow Transplant - A cure for Blood Cancer Dr. Rahul Bhargava29 Aug 2018 11:31 AM ISTIt is a common myth that bone marrow donation causes pain and hurts.With recent advances in the field of medical science, blood cancer is no more...
Gleevec Patent Expiry to bring financial benefits to patients savita thakur thakur17 March 2016 11:59 AM ISTNew York: Patients suffering from chronic myeloid leukemia (CML)-- a rare form of cancer -- can get huge financial benefits if they start using the...
